Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of Cocrystal Pharma, Inc. from 31 Dec 2014 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Cocrystal Pharma, Inc. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 31 Dec 2014 to 30 Sep 2024.
  • Cocrystal Pharma, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2024 was $13,095,000.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Cocrystal Pharma, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $13,095,000 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q4 2021 $58,755,000 31 Dec 2021 10-K 23 Mar 2022 2021 FY
Q3 2018 $4,713,000 +$3,368,000 +250% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $6,870,000 +$3,419,000 +99% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $1,278,000 -$277,000 -18% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $777,000 -$2,863,000 -79% 31 Dec 2017 10-Q 09 Nov 2018 2018 Q3
Q3 2017 $1,345,000 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $3,451,000 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $1,555,000 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $3,640,000 -$5,636,000 -61% 31 Dec 2016 10-Q 09 Nov 2018 2018 Q3
Q4 2015 $9,276,000 +$5,306,000 +134% 31 Dec 2015 10-K 21 Mar 2018 2017 FY
Q4 2014 $3,970,000 31 Dec 2014 10-K 21 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.